Loading…
This event has ended. Visit the official site or create your own event on Sched.
Welcome to the Science Summit at the United Nations General Assembly (UNGA77)

Please Register by clicking HERE

Registration is free of charge. You can register yourself and also other colleagues (up to 10 people).

After you have registered, you will receive two emails: one from Eventbrite with your ticket, and 15 min later, one from SCHED inviting you to create your username and password (these will be your  SCHED login details to access the conference each time).

Once you have your SCHED login details, you can select the session(s) you would like to attend and be able to see the ZOOM link to join your selected sessions.

All times in the AGENDA are New York Local (Eastern Daylight Time (EDT)). To view times in another time zone, please use the "Timezone" box located below on the right.
Back To Schedule
Wednesday, September 21 • 4:00pm - 6:30pm
(REF 21104) Chronic diseases in underserved populations: research and diagnostic strategies in autoimmune diseases and autoimmune interstitial lung diseases in Latin America.

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Feedback form is now closed.
1) Research in Latin America. Is it possible? Bernardo A. Pons-Estel.
2) Experience of the research group “Grupo Latinoamericano del Estudio de Enfermedades Reumáticas en Pueblos Originarios”(GLADERPO). Rosana Quintana.
3) Diagnostic strategies: The role of red cell distribution width (RDW) as an integrative measure of pathological processes for screening and monitoring autoimmune diseases. Mariana Lagrutta.
4) Autoimmune Interstitial lung diseases: the impact of regional research: EPIMAR Study group. Florencia Vivero.
5) Preventing disability through early diagnosis in Autoimmune Interstitial lung diseases. Juan Enghelmayer.
6) Conclusions: Mariana Lagrutta
Moderator: Guillermo Pons-Estel

Abstract:
Understanding the peculiar characteristics of our population with autoimmune diseases in Latin America, with particular emphasis on epidemiological issues, is crucial to developing strategies and facing future challenges in this area. Undertaking multi-center studies in Latin America enable us to understand more clearly the real-life scenario in our region and improve our insight into the impact of autoimmune disease. This path is essential to increasing the recognition of regional patients’ characteristics and behavior. Educational strategies destined for the community and primary care physicians are also valuable tools to improve patients’ and physicians’ awareness and reduce diagnostic delays. In particular, we emphasize the importance of reaching out to Indigenous People communities, sharing knowledge, and committing to mutual learning to achieve consensual treatment agreement according to their customs. This approach, which targets mutual understanding, reduces the breach that may be responsible for late diagnosis and delayed treatment or noncompliance.
Another topic of interest that has long been unrecognized and under-diagnosed is autoimmune Interstitial lung diseases. In the last decade, numerous studies have highlighted the high prevalence of an autoimmune etiology underlying interstitial lung disease. Its prompt recognition is essential to undergo specific treatment that significantly improves the prognosis of this otherwise highly disabling illness. Multi-center regional studies in our region significantly impact achieving this goal.
Regarding diagnostic strategies in autoimmune diseases based on analytical parameters, we analyze the role and impact of red cell distribution width (RDW). RDW is an inexpensive and routinely available laboratory parameter reported on all standard hemograms. It is an automated measure of the variation in red blood cell size or volume. A growing body of knowledge suggests that it is a potential integrative measure of pathological processes. RDW is a promising candidate biomarker for screening, monitoring inflammation, predicting disease activity, and prognostic stratification for several autoimmune diseases. This valid simple measure with reasonable accuracy is commonly overlooked, despite the need for inexpensive biomarkers for autoimmune disease management.
Early diagnosis and treatment is probably the best strategy to achieve more effective and economically feasible management of autoimmune diseases, improve outcomes, and reduce treatment costs and disability.


Speakers
avatar for Mariana Lagrutta

Mariana Lagrutta

President, Asociación de Medicina Interna de Rosario (AMIR)
President of the Rosario Internal Medicine Association (AMIR). Adjunct Professor of Internal Medicine and member of the academic committee of postgraduate specialization in Internal Medicine, Universidad Nacional de Rosario (UNR). Specialist in Internal Medicine and Magister in autoimmune... Read More →
avatar for Bernardo Pons-Estel

Bernardo Pons-Estel

Director, Regional Center for Autoimmune and Rheumatic Diseases (CREAR)
- Rheumatology specialist.- Former president of the Argentina Rheumatology Society.- Principal Coordinator of the Latin American Group for the Study of Lupus (GLADEL).- Principal Coordinator of the Latin American Group for Genome Study of Lupus (GLA-GENLES).- Co-Chair of the Latin... Read More →
avatar for Rosana Quintana

Rosana Quintana

Investigator, GLADERPO
Internal Medicine and Rheumatology specialist. Magister in Autoimmune diseases. PhD. Invetigator at Latin American Group for the Study of Rheumatic Diseases in Original Populations (GLADERPO). Centro Regional de Enfermedades Autoinmunes y Reumáticas(GO-CREAR), and Rosario Internal... Read More →
avatar for florencia vivero

florencia vivero

Physician Rheumatologist, Hospital Comunitario de Pinamar
Internal Medicine and Rheumatology specialist. Coordinator of the “Grupo De Studio De Enfermedad Pulmonary Intersticial de la Sociedad Argentina de Reumatología” (EPIMAR) Group, a Multicenter Cohort Study. Head of Rheumatology Section of the Hospital Comunitario de Pinamar, Pinamar... Read More →
avatar for Juan Enghelmayer

Juan Enghelmayer

Hospital de Clínicas. Universidad de Buenos Aires. Argentina
Pulmonologist. Specialized in Interstitial lung diseases. Hospital de Clínicas (UBA). Universidad de Buenos Aires. Staff of the Foundation for de study of fibrosing diseases (FUNEF). Former coordinator of the interstitial lung diseases section of the Argentina Respiratory Medicine... Read More →
avatar for Guillermo Pons-Estel

Guillermo Pons-Estel

Director, Argentina Rheumatology Society Research Unit (UNISAR).
Director of the Argentina Rheumatology Society Research Unit (UNISAR).Internal Medicine and Rheumatology specialist. Magister in Autoimmune diseases. PhD. Coordinator of the cohort GLADEL 2 of the Latin American Group for the Study of Lupus (GLADEL) and the Argentina Rheumatology... Read More →

Conveners
avatar for Mariana Lagrutta

Mariana Lagrutta

President, Asociación de Medicina Interna de Rosario (AMIR)
President of the Rosario Internal Medicine Association (AMIR). Adjunct Professor of Internal Medicine and member of the academic committee of postgraduate specialization in Internal Medicine, Universidad Nacional de Rosario (UNR). Specialist in Internal Medicine and Magister in autoimmune... Read More →


Wednesday September 21, 2022 4:00pm - 6:30pm EDT
Online